Distinct Transcriptional Control Mechanisms of Killer Immunoglobulin-like Receptors in Natural Killer (NK) and in T Cells*

Killer immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) cells and by subsets of CD4+ and CD8+ T cells, which are therefore thought to be subject to similar regulatory mechanisms. Here, we show that the transcriptional machinery to express KIR is limited to NK and T cells; however, the KIR transcriptional control differs between these two types of lymphocytes. T cells selectively express transcriptional activators binding to positions -52 to -61 of the KIR promoter, whereas an AML site around position-98 is relevant for transcription in NK cells. Although KIR expression is restricted to subsets of memory T cells, our studies demonstrate that transcriptional activators for KIRs are not acquired during T cell differentiation but are already present in naïve T cells, suggesting a basic role of KIRs in T cell biology. We suggest that the regulated expression of KIRs in T cells profoundly influences peripheral tolerance and antigen-specific immune responses.

[1]  L. Glimcher,et al.  Transcription: tantalizing times for T cells. , 2002, Cell.

[2]  L. Glimcher,et al.  c-maf Promotes T Helper Cell Type 2 (Th2) and Attenuates Th1 Differentiation by Both Interleukin 4–dependent and –independent Mechanisms , 1998, The Journal of experimental medicine.

[3]  T. Bellón,et al.  Natural killer cell activation and inhibition by receptors for MHC class I. , 1999, Current opinion in immunology.

[4]  J. Miller,et al.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. , 2001, Blood.

[5]  C. Weyand,et al.  CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. , 1996, The Journal of clinical investigation.

[6]  C. Weyand,et al.  CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. , 2001, Arthritis and rheumatism.

[7]  Peter Parham,et al.  Gene Structure and Promoter Variation of Expressed and Nonexpressed Variants of the KIR2DL5 Gene1 2 , 2000, The Journal of Immunology.

[8]  Michael J. Wilson,et al.  DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells , 2003, The Journal of experimental medicine.

[9]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[10]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[11]  Anjana Rao,et al.  TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes , 2002, Nature Immunology.

[12]  H. Ostrer,et al.  Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. , 1996, Journal of immunology.

[13]  H. Trompeter,et al.  Three Structurally and Functionally Divergent Kinds of Promoters Regulate Expression of Clonally Distributed Killer Cell Ig-Like Receptors (KIR), of KIR2DL4, and of KIR3DL31 , 2005, The Journal of Immunology.

[14]  A. Elmaagacli,et al.  Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. , 2005, Blood.

[15]  P. Parham,et al.  Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. , 2003, Blood.

[16]  Stephen Naylor,et al.  Molecular Basis for the Loss of CD28 Expression in Senescent T Cells* , 2002, The Journal of Biological Chemistry.

[17]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[18]  L. Moretta,et al.  Killer immunoglobulin-like receptors. , 2004, Current opinion in immunology.

[19]  W. O'Fallon,et al.  Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells1 , 2002, The Journal of Immunology.

[20]  P. Parham,et al.  The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.

[21]  R. Biassoni,et al.  Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes , 1997, Immunological reviews.

[22]  E. Vicaut,et al.  CD28 Expression in T Cell Aging and Human Longevity , 1998, Experimental Gerontology.

[23]  K. Hsu,et al.  The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.

[24]  É. Vivier,et al.  Differential regulation of killer cell Ig‐like receptors and CD94 lectin‐like dimers on NK and T lymphocytes from HIV‐1‐infected individuals , 1999, European journal of immunology.

[25]  P. Leibson The regulation of lymphocyte activation by inhibitory receptors. , 2004, Current opinion in immunology.

[26]  T. Spies,et al.  Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Farnham,et al.  T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. , 2004, Immunity.

[28]  J. Yen,et al.  Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1 , 2000, The Journal of Immunology.

[29]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[30]  P. Parham Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. , 2004, Immunology letters.

[31]  M. Carrington,et al.  Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis1 , 2004, The Journal of Immunology.

[32]  M. Bonneville,et al.  Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 , 2001, The Journal of Immunology.

[33]  S. Ferrini,et al.  Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. , 1995, International immunology.

[34]  H. Trompeter,et al.  Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells1 , 2002, The Journal of Immunology.

[35]  L. Lanier,et al.  The developmental relationship between NK cells and T cells. , 1992, Immunology today.

[36]  P. Leibson,et al.  Stimulatory Killer Ig-Like Receptors Modulate T Cell Activation through DAP12-Dependent and DAP12-Independent Mechanisms1 , 2004, The Journal of Immunology.

[37]  J. Trowsdale,et al.  Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters1 , 2003, The Journal of Immunology.

[38]  R. Toes,et al.  Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells , 2001, Nature Immunology.

[39]  L. Karlsson,et al.  A subpopulation of CD8+ T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance , 2000, European journal of immunology.

[40]  A. Vallejo,et al.  Aging-related Deficiency of CD28 Expression in CD4+ T Cells Is Associated with the Loss of Gene-specific Nuclear Factor Binding Activity* , 1998, The Journal of Biological Chemistry.

[41]  S. Szabo,et al.  Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.

[42]  A. Vallejo,et al.  T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. , 2004, Trends in molecular medicine.

[43]  P. Beverley Kinetics and clonality of immunological memory in humans. , 2004, Seminars in immunology.

[44]  B. Koeleman,et al.  KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. , 2003, Diabetes.

[45]  D. F. Barber,et al.  Inhibition of natural killer cell activation signals by killer cell immunoglobulin‐like receptors (CD158) , 2001, Immunological reviews.

[46]  É. Vivier,et al.  Biology of T memory type 1 cells , 2001, Immunological reviews.

[47]  A. Vallejo,et al.  Functional Disruption of the CD28 Gene Transcriptional Initiator in Senescent T Cells* , 2001, The Journal of Biological Chemistry.

[48]  C. Figdor,et al.  Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. , 1998, Journal of immunology.

[49]  Richard A Flavell,et al.  The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.

[50]  P. Parham,et al.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.

[51]  W. Yokoyama,et al.  The dynamic life of natural killer cells. , 2004, Annual review of immunology.

[52]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[53]  R. Frye,et al.  De Novo Expression of Killer Immunoglobulin‐Like Receptors and Signaling Proteins Regulates the Cytotoxic Function of CD4 T Cells in Acute Coronary Syndromes , 2003, Circulation research.

[54]  Michael J. Wilson,et al.  Killer Cell Ig-Like Receptor and Leukocyte Ig-Like Receptor Transgenic Mice Exhibit Tissue- and Cell-Specific Transgene Expression 1 , 2003, The Journal of Immunology.

[55]  L. Lanier NK cell receptors. , 1998, Annual review of immunology.

[56]  T. Ottenhoff,et al.  Phenotypic and Functional Characterization of CD4 T Cells Expressing Killer Ig-Like Receptors1 , 2004, The Journal of Immunology.

[57]  Graham M Lord,et al.  Recent developments in the transcriptional regulation of cytolytic effector cells , 2004, Nature Reviews Immunology.

[58]  M. Snyder,et al.  The double life of NK receptors: stimulation or co-stimulation? , 2004, Trends in immunology.

[59]  Daniel J. Schaid,et al.  Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis , 2001, The Journal of experimental medicine.

[60]  Michael J. Wilson,et al.  Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 , 2002, The Journal of Immunology.

[61]  M. Mańczak,et al.  Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. , 2004, Human immunology.

[62]  O. Mandelboim,et al.  Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.

[63]  Michael J. Wilson,et al.  The genomic context of natural killer receptor extended gene families , 2001, Immunological reviews.

[64]  É. Vivier,et al.  Selective Activation of the c-Jun NH2-terminal Protein Kinase Signaling Pathway by Stimulatory KIR in the Absence of KARAP/DAP12 in CD4+ T Cells , 2003, The Journal of experimental medicine.